These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 27567296)

  • 1. Ozagrel for Patients With Noncardioembolic Ischemic Stroke: A Propensity Score-Matched Analysis.
    Wada T; Yasunaga H; Horiguchi H; Fushimi K; Matsubara T; Nakajima S; Yahagi N
    J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2828-2837. PubMed ID: 27567296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective Analysis of Argatroban in 353 Patients with Acute Noncardioembolic Stroke.
    Oguro H; Mitaki S; Takayoshi H; Abe S; Onoda K; Yamaguchi S
    J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2175-2181. PubMed ID: 29706441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Argatroban Treatment in Patients With Atherothrombotic Stroke: Observational Nationwide Study in Japan.
    Wada T; Yasunaga H; Horiguchi H; Matsubara T; Fushimi K; Nakajima S; Yahagi N
    Stroke; 2016 Feb; 47(2):471-6. PubMed ID: 26670085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Edaravone (radical scavenger) versus sodium ozagrel (antiplatelet agent) in acute noncardioembolic ischemic stroke (EDO trial).
    Shinohara Y; Saito I; Kobayashi S; Uchiyama S
    Cerebrovasc Dis; 2009; 27(5):485-92. PubMed ID: 19321945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinical effect of combination therapy with edaravone and sodium ozagrel for acute cerebral infarction].
    Takabatake Y; Uno E; Wakamatsu K; Yamazaki N; Hashimoto N; Tsuchiya Y
    No To Shinkei; 2003 Jul; 55(7):589-93. PubMed ID: 12910992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sodium ozagrel on hemostatic markers and cerebral blood flow in lacunar infarction.
    Oishi M; Mochizuki Y; Hara M; Yoshihashi H; Takasu T
    Clin Neuropharmacol; 1996 Dec; 19(6):526-31. PubMed ID: 8937792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical effects of urokinase and sodium ozagrel in patients with acute symptomatic lacunar infarction].
    Sakamoto T; Harimoto K; Inoue S; Konishi A
    No To Shinkei; 1996 Sep; 48(9):805-9. PubMed ID: 8888028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ozagrel for acute ischemic stroke: a meta-analysis of data from randomized controlled trials.
    Zhang J; Yang J; Chang X; Zhang C; Zhou H; Liu M
    Neurol Res; 2012 May; 34(4):346-53. PubMed ID: 22643078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. To Load or Not to Load? Aspirin Loading in Acute Ischemic Stroke: A Study of Clinical Outcomes.
    Su TH; Chan YL; Lee JD; Lee M; Lin LC; Wen YW; Lee TH
    J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2439-47. PubMed ID: 27388708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
    Anaissie JE; Monlezun DJ; Siegler JE; Waring ED; Dowell LN; Samai AA; George AJ; Kimbrough T; Berthaud J; Martin-Schild S
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2603-2609. PubMed ID: 27476340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ozagrel, a selective thromboxane A2-synthetase inhibitor, on cerebral infarction in rats. Comparative study with norphenazone, a free-radical scavenger.
    Imamura T; Kiguchi S; Kobayashi K; Ichikawa K; Yamazaki Y; Kojima M
    Arzneimittelforschung; 2003; 53(10):688-94. PubMed ID: 14650360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical effects of sodium ozagrel and urokinase in patients with acute cerebral infarction in the territory of the internal carotid artery].
    Itoh H; Yamatani K; Oshida N; Shioi M; Takaba M; Kamiyama H; Itoh M
    No To Shinkei; 1998 Feb; 50(2):147-55. PubMed ID: 9513204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of smoking in patients with acute ischemic stroke within 3 months of onset.
    Kumagai N; Origasa H; Nagao T; Takekawa H; Okuhara Y; Yamaguchi T
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):792-8. PubMed ID: 22633681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modest association between the discharge modified Rankin Scale score and symptomatic intracerebral hemorrhage after intravenous thrombolysis.
    Asuzu D; Nystrom K; Amin H; Schindler J; Wira C; Greer D; Chi NF; Halliday J; Sheth KN
    J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):548-53. PubMed ID: 25540072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Oral Antiplatelet Agents and Tirofiban on Functional Outcomes of Patients with Non-Disabling Minor Acute Ischemic Stroke.
    Wang H; Li X; Liu C; Huang S; Liang C; Zhang M
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104829. PubMed ID: 32689578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of plasma adiponectin for diagnosis, neurological severity and functional outcome in ischemic stroke - Research for Biomarkers in Ischemic Stroke (REBIOS).
    Kuwashiro T; Ago T; Kamouchi M; Matsuo R; Hata J; Kuroda J; Fukuda K; Sugimori H; Fukuhara M; Awano H; Isomura T; Suzuki K; Yasaka M; Okada Y; Kiyohara Y; Kitazono T
    Metabolism; 2014 Sep; 63(9):1093-103. PubMed ID: 24929894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of fasudil monotherapy and fasudil-ozagrel combination therapy in patients with subarachnoid hemorrhage: sub-analysis of the post-marketing surveillance study.
    Suzuki Y; Shibuya M; Satoh S; Sugiyama H; Seto M; Takakura K
    Neurol Med Chir (Tokyo); 2008 Jun; 48(6):241-7; discussion 247-8. PubMed ID: 18574328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical analysis for efficacy of tirofiban combined with ozagrel in the treatment of progressive cerebral infarction patients out of thrombolytic therapy time window.
    Zhang H; Zheng L
    Clinics (Sao Paulo); 2021; 76():e2728. PubMed ID: 34133479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combined treatment for acute larger lacunar-type infarction.
    Yamamoto Y; Ohara T; Ishii R; Tanaka E; Murai T; Morii F; Tamura A; Oohara R
    J Stroke Cerebrovasc Dis; 2011; 20(5):387-94. PubMed ID: 20656510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator.
    Xian Y; Federspiel JJ; Grau-Sepulveda M; Hernandez AF; Schwamm LH; Bhatt DL; Smith EE; Reeves MJ; Thomas L; Webb L; Bettger JP; Laskowitz DT; Fonarow GC; Peterson ED
    JAMA Neurol; 2016 Jan; 73(1):50-9. PubMed ID: 26551916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.